Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Chinese Patent Office
Cipla
Boehringer Ingelheim
AstraZeneca
Mallinckrodt
UBS
Fuji
Federal Trade Commission
Argus Health

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,679,717

« Back to Dashboard

Summary for Patent: 5,679,717
Title: Method for removing bile salts from a patient with alkylated amine polymers
Abstract:A method for removing bile salts from a patient that includes administering to the patient a therapeutically effective amount of product produced by a process comprising alkylating one or more crosslinked amine polymers, salts or copolymers thereof with at least one alkylating agent. The reaction product is characterized in that: (i) at least some of the nitrogen atoms are unreacted with alkylating agent; and (ii) less than 10 mol% of the nitrogen atoms in the polymer react with the alkylating agent to form quaternary ammonium units.
Inventor(s): Mandeville, III; W. Harry (Lynnfield, MA), Holmes-Farley; Stephen Randall (Arlington, MA)
Assignee: GelTex Pharmaceuticals, Inc. (Waltham, MA)
Application Number:08/460,980
Patent Claim Types:
see list of patent claims
Use; Process; Compound;

Drugs Protected by US Patent 5,679,717

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,679,717

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Israel 142419 ➤ Subscribe
Israel 114073 ➤ Subscribe
Japan H09500368 ➤ Subscribe
Japan 3931217 ➤ Subscribe
Israel 122383 ➤ Subscribe
Hong Kong 1001611 ➤ Subscribe
Spain 2164152 ➤ Subscribe
Greece 3031702 ➤ Subscribe
Spain 2135743 ➤ Subscribe
European Patent Office 0909768 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Accenture
Mallinckrodt
UBS
Harvard Business School
McKinsey
Deloitte
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot